Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
MHC-class-II are expressed in a subpopulation of human neural stem cells in vitro in an IFNγ-independent fashion and during development.
Optic neuritis as first clinical manifestations the multiple sclerosis.
A Case of Neuromyelitis Optica Masquerading as Miller Fisher Syndrome.
Predictive Value of Baseline Electronic Columbia-Suicide Severity Rating Scale (eC-SSRS) Assessments for Identifying Risk of Prospective Reports of Suicidal Behavior During Research Participation.
Oligodendroglial Development: New Roles for Chromatin Accessibility.
Nonapoptotic and Extracellular Activity of Granzyme B Mediates Resistance to Regulatory T Cell (Treg) Suppression by HLA-DR-CD25hiCD127lo Tregs in Multiple Sclerosis and in Response to IL-6.
A rare brain infection with multiple sclerosis dug.
Emerging injectable therapies for multiple sclerosis.
Myelin alters the inflammatory phenotype of macrophages by activating PPARs.
Current and Future Therapies for Multiple Sclerosis.
Validation of the Neurological Fatigue Index for Stroke (NFI-Stroke).
Modulation of Immune response by Ultra-violet light in HLA class-II transgenic mice.
Exploring strategies used following a group-based fatigue management programme for people with multiple sclerosis (FACETS) via the Fatigue Management Strategies Questionnaire (FMSQ).
Mechanisms of sodium channel clustering and its influence on axonal impulse conduction.
Neuromyelitis optica presenting as intractable vomiting and hyperCKaemia.
Methylprednisolone induced liver injury: Case report and literature review.
Linear lesions may assist early diagnosis of neuromyelitis optica and longitudinally extensive transverse myelitis, two subtypes of NMOSD.
Distinct roles of T-cell lymphopenia and the microbial flora for gastrointestinal and CNS autoimmunity.
Role of Subventricular Zone Derived Neural Precursor Cells in the Therapy of Experimental Autoimmune Encephalomyelitis.
Effectiveness and Tolerability of THC/CBD Oromucosal Spray for Multiple Sclerosis Spasticity in Italy: First Data from a Large Observational Study.
Neuro-immune dysfunction during brain aging: new insights in microglial cell regulation.
Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination.
Mesenchymal stem cells of dental origin - their potential for anti-inflammatory and regenerative actions in brain and gut damage.
Urinary tract infections in multiple sclerosis.
Impaired retinal microcirculation in multiple sclerosis.
Pages
« first
‹ previous
…
645
646
647
648
649
650
651
652
653
…
next ›
last »